<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C754D612-4D8B-42CB-922C-07E7F5BE4B49"><gtr:id>C754D612-4D8B-42CB-922C-07E7F5BE4B49</gtr:id><gtr:name>Washington University in St. Louis</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C4ED5B1E-E265-4B92-8BF2-EBDB7897E0CF"><gtr:id>C4ED5B1E-E265-4B92-8BF2-EBDB7897E0CF</gtr:id><gtr:name>Centers for Disease Control and Prevention (CDC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/734F19C1-61E5-45B1-A183-63FDD145328F"><gtr:id>734F19C1-61E5-45B1-A183-63FDD145328F</gtr:id><gtr:name>World Health Organization (WHO)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/93B13D3A-863C-46E8-A4C7-1EE4759A7E9B"><gtr:id>93B13D3A-863C-46E8-A4C7-1EE4759A7E9B</gtr:id><gtr:name>Cleveland Clinic</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/82F274CB-C3AA-445B-9714-3CF56785F38E"><gtr:id>82F274CB-C3AA-445B-9714-3CF56785F38E</gtr:id><gtr:name>Johns Hopkins University</gtr:name><gtr:address><gtr:line1>3400 North Charles Street</gtr:line1><gtr:line4>Baltimore</gtr:line4><gtr:line5>MD 21218</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:department>Clinical Sciences</gtr:department><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C754D612-4D8B-42CB-922C-07E7F5BE4B49"><gtr:id>C754D612-4D8B-42CB-922C-07E7F5BE4B49</gtr:id><gtr:name>Washington University in St. Louis</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C4ED5B1E-E265-4B92-8BF2-EBDB7897E0CF"><gtr:id>C4ED5B1E-E265-4B92-8BF2-EBDB7897E0CF</gtr:id><gtr:name>Centers for Disease Control and Prevention (CDC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/734F19C1-61E5-45B1-A183-63FDD145328F"><gtr:id>734F19C1-61E5-45B1-A183-63FDD145328F</gtr:id><gtr:name>World Health Organization (WHO)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/93B13D3A-863C-46E8-A4C7-1EE4759A7E9B"><gtr:id>93B13D3A-863C-46E8-A4C7-1EE4759A7E9B</gtr:id><gtr:name>Cleveland Clinic</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/82F274CB-C3AA-445B-9714-3CF56785F38E"><gtr:id>82F274CB-C3AA-445B-9714-3CF56785F38E</gtr:id><gtr:name>Johns Hopkins University</gtr:name><gtr:address><gtr:line1>3400 North Charles Street</gtr:line1><gtr:line4>Baltimore</gtr:line4><gtr:line5>MD 21218</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/7D583458-E5F2-4C89-894E-574499A53338"><gtr:id>7D583458-E5F2-4C89-894E-574499A53338</gtr:id><gtr:firstName>Tom</gtr:firstName><gtr:surname>Solomon</gtr:surname><gtr:orcidId>0000-0001-7266-6547</gtr:orcidId><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G116%2F194"><gtr:id>73199DC8-1150-4229-A347-2A73E43556A3</gtr:id><gtr:title>INFLAMMATION IN JAPANESE ENCEPHALITIS - THE ROLE OF INTERLEUKIN 6</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G116/194</gtr:grantReference><gtr:abstractText>Japanese encephalitis virus is globally the most important insect-borne virus that infects the brain to cause encephalitis (swelling) and death. It is found in Asia, but is closely related to West Nile virus, which has caused outbreaks of encephalitis in America and Europe, and is spreading. There is no treatment for these diseases. I have been studying Japanese encephalitis for 10 years. Our recent studies on humans with Japanese encephalitis suggest that the body?s own immune response to the infection may be doing more harm than good. In particular one of the proteins produced in the brain (IL-6) causes leakiness in the blood brain barrier (the lining between the blood vessels and the brain), allowing fluid into the brain, and causing brain swelling, and death. In this Fellowship I examine this problem in more detail by looking at the amount of virus, the amount of IL-6 protein, where the protein comes from, and what effect it has on the blood brain barrier. I also look at potential new treatments that stop this damaging chain of events. This work will point the way towards new treatments for Japanese encephalitis and related conditions.</gtr:abstractText><gtr:technicalSummary>Japanese encephalitis (JE) virus is the most important cause of epidemic viral encephalitis worldwide, with approximately 35-50,000 cases and 10-15,000 deaths annually. Although vaccines exist for JE, they are not available for most of the people in rural Asia that need them, because of issues over cost and production. Like the closely related West Nile virus, which has caused large outbreaks in southern Europe and the United States, this mosquito-borne flavivirus is spreading, and there is no established treatment. However there is increasing evidence that in JE, as in other RNA viral central nervous system (CNS) infections, a poorly regulated immune response may contribute to the pathogenesis - and this may be amenable to treatment. 
 We have recently found JE patients with high levels of IL-6 in the cerebrospinal fluid (CSF) are much more likely to die. This pro-inflammatory cytokine is produced by various CNS cells in response to viral infection. Whilst IL-6 may be protective at low levels, high levels can cause increased permeability of the blood brain barrier leading to cerebral oedema and death. Such high levels may be a response to the particular viral strain viral load, or they may be host specific. 
 In this Fellowship I will test the hypothesis that in JE over-production of IL-6 leads to increased blood brain barrier permeability and cerebral oedema, and makes an important contribution to death. 
Using CSF, plasma and autopsy samples collected from humans with JE I will examine the relationship between IL-6, blood brain barrier function, and viral load. I will then use the well-established mouse model to address the same questions; but in the model I have the additional advantage of being able to control the viral strain and inoculum, and the host strain. In addition, I will use IL-6 knockout mice, and anti-IL-6 antibodies to further delineate the pathogenesis. Finally I will use this model to examine the effect of anti-inflammatory drugs on IL-6, blood brain barrier permeability, and fatality in the mouse model of JE. Anti-inflammatory drugs offer one of the best potentials for treatment of JE in humans, and these preclinical studies will be a critical prelude towards developing rationale treatment for this devastating disease</gtr:technicalSummary><gtr:fund><gtr:end>2011-04-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>946687</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs><gtr:artisticAndCreativeProductOutput><gtr:description>Popular science book</gtr:description><gtr:id>8CF5539A-FDD3-4B7D-B27A-760FDA0CAF18</gtr:id><gtr:impact>TV, radio, newspaper coverage
speeches, lectures, appearances at literary and science festivals
children's show</gtr:impact><gtr:outcomeId>58be8e3c5d2548.87668364</gtr:outcomeId><gtr:title>Roald Dahl's Marvellous Medicine</gtr:title><gtr:type>Creative Writing</gtr:type><gtr:url>http://www.tomsolomon.co.uk</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:artisticAndCreativeProductOutput></gtr:artisticAndCreativeProductOutputs><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>World Health Organization (WHO)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>World Health Organisation Japanese encephalitis Laboratory Diagnostic Network</gtr:description><gtr:id>A3FD9266-7858-489D-A920-C31BFBDCEE7F</gtr:id><gtr:impact>The network is standaridising the approaches to diagnosis of Japanese encephalitis across the Asia-Pacific Region to allow improved management and better determination of disease incidence. Publications in preparation</gtr:impact><gtr:outcomeId>00EB512F5D7-1</gtr:outcomeId><gtr:partnerContribution>Standardising the diagnostic approaches to Japanese encephalitis facilitates research on this disease</gtr:partnerContribution><gtr:piContribution>Took a lead role in establishing the Network</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Johns Hopkins University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Johns Hopkins, Baltimore, USA (Monique Stins)</gtr:description><gtr:id>CDF72CC4-3B17-4A65-9BB7-598FFF7D4E90</gtr:id><gtr:impact>see publications</gtr:impact><gtr:outcomeId>Q3jCpUgj9HC-1</gtr:outcomeId><gtr:partnerContribution>new Post Doc Fellowship funded by Hadwen Trust</gtr:partnerContribution><gtr:piContribution>Johns Hopkins, Baltimore, USA (Monique Stins); an in vitro model of the blood brain barrier; since 2009)</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Oxford Vaccine Group</gtr:department><gtr:description>Oxford Vaccine Group</gtr:description><gtr:id>6B49BEFB-E396-415D-9235-16A6843591A8</gtr:id><gtr:impact>early days</gtr:impact><gtr:outcomeId>N6Q1bpQ6MDF-1</gtr:outcomeId><gtr:partnerContribution>new collaboration</gtr:partnerContribution><gtr:piContribution>new collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Centers for Disease Control and Prevention (CDC)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Vector-borne diseases</gtr:department><gtr:description>Centre for Disease Control, Atlanta, Georgia, USA</gtr:description><gtr:id>9FE1D23D-03BF-4EB7-A0B5-6086D8A08644</gtr:id><gtr:impact>SEE PUBLICATIONS</gtr:impact><gtr:outcomeId>smCJ6bG1qwL-1</gtr:outcomeId><gtr:partnerContribution>collaboration</gtr:partnerContribution><gtr:piContribution>(Marc Fischer, Susan Hills, Japanese encephalitis control, since 2008)</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cleveland Clinic</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Lerner Research Institute</gtr:department><gtr:description>Neuroinflammation Research Unit, Lerner Institute, Cleveland (Richard Ransohoff)</gtr:description><gtr:id>38CDE6B2-1C29-4E8B-82CB-C3DE7873AC8D</gtr:id><gtr:impact>see publications</gtr:impact><gtr:outcomeId>NnjrurH5kPp-1</gtr:outcomeId><gtr:partnerContribution>development of new blood brain barrier model</gtr:partnerContribution><gtr:piContribution>Neuroinflammation Research Unit, Lerner Institute, Cleveland (Richard Ransohoff, blood brain barrier model since 2009)
Post Doctoral Research Fellowship funded by Hadwen Trust
dr Adjanie Patabendige</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Washington</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Pathogen discovery</gtr:description><gtr:id>8B65E566-A1B5-4E3B-AB3B-1233AF46AF14</gtr:id><gtr:impact>see publications</gtr:impact><gtr:outcomeId>bkg1BeGEAX7-1</gtr:outcomeId><gtr:partnerContribution>Pathogen discovery work</gtr:partnerContribution><gtr:piContribution>Washington University, St Louis (David Wang and Mike Diamond, Pathogen discovery and Flavivirus epitope mapping since 2009)</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>World's Biggest Brain Guinness Record-Winning Interactive Event for World Encephalitis day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7C772851-F968-4536-AF71-FABC9A7D754E</gtr:id><gtr:impact>raised awareness of encephalitis among the 800 partiicipants, and the 3500 people who viewed the video on YouTube, plus the tens of thousands around the world who read news articles about the event

Much greater interest in the disease encephalitis itself, and other forms of brain disease, plus the research of the University of Liverpool in this areas</gtr:impact><gtr:outcomeId>545d4766ae2866.61650819</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://www.liv.ac.uk/infection-and-global-health/news/articles/university-of-liverpool-has-the-worlds-biggest-brain/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>International Women's Day March 2013</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>45CAAEE0-FF8A-4920-9FD4-BDF8D826475A</gtr:id><gtr:impact>I initiated, on behalf of the Institute I lead (IGH-Liverpool), an interactive exhibit at the Royal Liverpool Hospital on March 8th to celebrate International Women's Day. 
The exhibit featured a photographic mosaic of Kitty, who was known as the Saint of the Slums for her work during a 1832 Liverpool cholera epidemic, created using the images of current female staff and researchers from IGH whose work builds on her legacy.
There was also a display featuring the Women of the Institute; staff nominated by their colleagues for being an inspiration to others through their commitment to research, charity work, helpfulness and more.
Visitors joined in by reflecting on the women who inspire them, and adding their names and thoughts to a collective. 
The event was a great success and we met lots of lovely people with interesting stories to tell. Some people even remembered the wash houses of Liverpool that Kitty helped create!

Much more recognition of the role of women in scienc,e both today and in the past</gtr:impact><gtr:outcomeId>GwDdMwBBuKj</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://www.facebook.com/media/set/?set=a.470397199680727.1073741825.184437834943333&amp;type=3</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Brain Awareness Week</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>13EFF670-F3F4-4606-8100-618C5318BF4C</gtr:id><gtr:impact>I devised and led a one week roadshow &amp;quot;Battle of the Brain Bugs&amp;quot; which toured local partner instituions (hospitals and universities), and culminated in an interactive event at the Liverpool World Museum; this was the launch of y Institutes Saturday Science Programme at the Museum

increased interest from the public, school children, and collaborators</gtr:impact><gtr:outcomeId>HHsyYWUtpZm</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>TEDx Talk: Sex Drugs and Emerging Viruses - Tom Solomon</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>031B4235-D902-4E62-9DF7-EBA6574CBD0D</gtr:id><gtr:impact>Broader discussion around the issues

2000 hits on Youtube, so far
plus increased followers on Twitter</gtr:impact><gtr:outcomeId>545d4a840667c9.85178922</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://www.youtube.com/watch?v=tySFXZ-ABZA</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Encephalitis Society Professional Advisory Panel</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>D29B85CD-01A6-474F-9150-A91D7E3E707A</gtr:id><gtr:impact>Regular advisor to the encephalitis society, at professioanl advisory panel meetings, plus through meetings with its lay members and public

Improved understanding</gtr:impact><gtr:outcomeId>AEC0255ADC8</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006,2007,2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Schools Visit</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>CB0E05EC-F446-4B14-B461-3313C95306B9</gtr:id><gtr:impact>&amp;quot;My Brilliant Brain&amp;quot; - As part of the University's engagement with local communities, and public understanding of science role I introduced 8-year old school children to the brain, how it works, and what can go wrong with it. 2008.

Invited back to do further work</gtr:impact><gtr:outcomeId>E67A6AD860C</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006,2007,2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Centenary Event</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>35C29CDA-643A-4AA1-95DC-51FC5DD178CC</gtr:id><gtr:impact>In celebration of 100 years of the Medical Research Council (MRC), scientists at the University's Institute of Infection and Global Health presented their work on brain infections, called Japanese encephalitis, in India and Nepal to a public audience at the Victoria Gallery and Museum. The film of their work shows photography taken by Liverpool researchers during their research trips to the region.

Professor Tom Solomon said: &amp;quot;Initial clinical symptoms of encephalitis can be subtle and therefore identifying the disease early can be difficult. With the support of the MRC we aim to raise awareness of the disease so that hospital doctors know what to look for when a patient comes in with suspected viral infection.&amp;quot;

Positive discussions afterwards</gtr:impact><gtr:outcomeId>YZP494CwPZY</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.liv.ac.uk/infection-and-global-health/news/articles/film-battling-brain-infections-in-asia/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Scientific Advisor and Expert on  TV Series</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>5048E7C2-AED8-4E4B-80AA-C7BA8FB66D2C</gtr:id><gtr:impact>I was the Scientific Advisor, and appeared several times in this highly acclaimed ITV series for Channel Four, which introduced key concepts in neuroscience, including the devastation caused by encephalitis, through case studies of people with rare but fascinating neurological afflictions

Lots of interesting discussions afterwards in the news media</gtr:impact><gtr:outcomeId>E02A4EE8BA2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The Emrys Jones Lecture 2013. Merchant Taylors' Schools, Liverpool, UK 26 September 2013 ?</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>B23DBCB2-4C93-4C93-AD90-972DBCCB3B90</gtr:id><gtr:impact>From the School Website:-

A Memorable Lecture from the &amp;quot;Running Mad Professor&amp;quot;!
Back to News
Merchant Taylors' Schools in Liverpool were delighted to welcome Professor Tom Solomon as their Guest Speaker for the Emrys Jones Lecture. This annual event has been made possible through an endowment given by Emrys Jones (a pupil at Merchant Taylors' Boys' School from 1918-1924) in 1959, so that a lecture could be given to the pupils every year, by a person of high achievement. For over five decades now the Lecture has attracted high-calibre speakers from many different walks of life, including Peter Scott and Group Captain Douglas Bader in the 60's, Chris Bonington in the 70's, John Dankworth in the 80's, Steve Redgrave CBE in the 90's and Tanni Grey-Thompson in the &amp;quot;noughties&amp;quot;.
Following in these illustrious footsteps, Professor Tom Solomon delivered a wonderful and memorable lecture to the boys and girls. Professor Solomon was brought up in Manchester, and studied medicine in Oxford, before working on brain infections in Vietnam, with a Wellcome Trust Training Fellowship. He then became Clinical Lecturer at the University of Liverpool, and was awarded a Wellcome Trust Career Development Fellowship, with two years in the USA. Returning to Liverpool, he became Senior Lecturer, MRC Senior Clinical Fellow, then Chair of Neurological Science, and Director of the Liverpool Institute of Infection and Global Health, which has 100 leading scientists working on major infection and global health issues in a new state-of-the-art &amp;pound;35 million facility.
Professor Solomon also heads the multi-disciplinary Brain Infections Group, which studies brain infections of major global importance with collaborations in Asia, Africa, the UK and the US. The group has more than &amp;pound;6M in funding principally from MRC, Wellcome Trust, Gates Foundation, and NIHR. He has published more than 20 book chapters and 80 papers in the medical journals and is as an advisor to the US National Institutes for Health, the WHO, the UK Health Protection Agency, and the Encephalitis Society.
Professor Solomon's work on Public Understanding of Science and Widening Participation has included acting as Scientific Advisor and appearing in the ITV series &amp;quot;My Strange Brain&amp;quot; (2008), appearances on BBC TV, and contributing regularly to local radio. His schools work has ranged from small group discussions in local primary schools to giving the Scholar's Day Lecture at Shrewsbury School (2012).
He established the Saturday Science Programme at World Museum Liverpool, but is perhaps best known for his role as the Running Mad Professor, with nearly 20,000 YouTube hits, running the Virgin London Marathon in 2010, and winning the Guinness World Record for the fastest marathon dressed as a doctor (4 hours, 20 minutes 19 seconds!)
Following the lecture Professor Solomon said &amp;quot;It was a great honour to give this lecture, especially considering the extremely high calibre of some of the lecturers from previous years. I enjoyed finding out more about the school, and meeting the students. The discussion with the students was especially enjoyable, and they had some very challenging questions!&amp;quot;
If anyone wishes to follow the work of Professor Solomon then there is a Facebook page for the Liverpool Institute of Infection and Global Health. To hear about future events and opportunities please email Nic Frost nfrost@liverpool.ac.uk and ask to be put on the &amp;quot;Friends of IGH&amp;quot; mailing list.

Increased interest from the school children, and their parents, in the research we are doing</gtr:impact><gtr:outcomeId>545d48ad6eead2.43116871</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://www.merchanttaylors.com/senior-boys/a-memorable-lecture-from-the-running-mad-professor.html</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Panel Discussant - Bon Voyage: Travel, health and disease, hosted by BBC Radio 4's Quentin Cooper</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>250A151F-78BD-4378-A8FB-4FC3628F9DAC</gtr:id><gtr:impact>Panel Discussant - Bon Voyage: Travel, health and disease, hosted by BBC Radio 4's Quentin Cooper at World Museum Liverpool, in conjunction with British Society for Immunology

7th Dec, 2011

-</gtr:impact><gtr:outcomeId>tNnmRmyrbsQ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Brain on Fire</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>58ED6C89-55EF-4B3E-9161-B3DB0D5FBA07</gtr:id><gtr:impact>The Institute of Infection and Global Health organised an event at Waterstones Bookshop Liverpool One on Wednesday 28th August which saw ?New York Post bestselling author Susannah Cahalan discuss her book Brain on Fire: My Month of Madness (about her experinces of egtting encephalitis) alongside the Institute's Professor Tom Solomon. The event was well attended and the audience included clinicians, Encephalitis Society members, fans of the book and interested members of the public. Many people stayed behind at the end to chat to Susannah and Tom further, and a large queue formed for Susannah to sign copies of the newly released paperback edition of the book.

Earlier in the day Tom and Susannah also presented a lunchtime lecture aimed specifically at clinicians at the Walton Centre, a major neurology hospital in Liverpool

Plans for further public engagement work together in the future</gtr:impact><gtr:outcomeId>nPWEMuBRuz6</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.liv.ac.uk/infection-and-global-health/news/stories/title,348842,en.html</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Expert for the Science Media centre</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>2C19ECBB-97A6-489D-9D74-01BC283A8C29</gtr:id><gtr:impact>This organisation which is an independent venture working to promote the voices, stories and views of the scientific community to the national news media when science is in the headlines.</gtr:impact><gtr:outcomeId>8F2032B1B90</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Expert</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>F6FF2D36-A7DC-45E4-B191-056A56AAA664</gtr:id><gtr:impact>Expert Advisor for several news media articles from local and national newspapers and magazines (Times, Woman's Own, etc)

Better public understanding of scientific issues</gtr:impact><gtr:outcomeId>8EE8A12A771</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>752210</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Leverhulme Trust Programme Grant</gtr:description><gtr:end>2012-01-02</gtr:end><gtr:fundingOrg>The Leverhulme Trust</gtr:fundingOrg><gtr:id>4D505B2F-B5D6-4185-83A4-34DC6EBA202C</gtr:id><gtr:outcomeId>6543040367B0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2038353</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Health Technology Assessment Programme (BASICS study)</gtr:description><gtr:end>2017-01-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>10/104/30</gtr:fundingRef><gtr:id>85CB3B13-5682-42A8-9571-547C9A347CA8</gtr:id><gtr:outcomeId>Np7W4HD2F3h</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1100000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>European Union Horizon 2020</gtr:description><gtr:end>2020-09-02</gtr:end><gtr:fundingOrg>European Union</gtr:fundingOrg><gtr:id>BC1C5C6E-FECA-4278-B38D-2797E84F95B2</gtr:id><gtr:outcomeId>58be8a6dbc5cc5.95929971</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2030000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Programme Grant</gtr:description><gtr:end>2015-01-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>D66ABD9B-6CA1-440F-894C-A287445CDF2E</gtr:id><gtr:outcomeId>37D09762EFA0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2136846</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC/NIHR Efficacy and Mechanism Evaluation (EME) Programme. Intravenous immunoglobulin for the treatment of children with encephalitis.</gtr:description><gtr:end>2018-11-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>E5B1A441-DDE8-425C-919A-64B5B51C89ED</gtr:id><gtr:outcomeId>545d41ee419a63.92000548</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>400000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Doctoral Training Fellowship (Dr Fiona McGill)</gtr:description><gtr:end>2016-01-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>308865B4-6154-4A25-B60D-6B438910FB81</gtr:id><gtr:outcomeId>XmkXQ6Wfb8Q</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant, VLA</gtr:description><gtr:end>2012-01-02</gtr:end><gtr:fundingOrg>Veterinary Laboratories Agency</gtr:fundingOrg><gtr:id>D3790DA3-C4B4-4F6B-AE4E-4D534CA5B758</gtr:id><gtr:outcomeId>osGPPRK8roF</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3909867</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Health Protection Research Unit in Emerging and Zoonotic Infections</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>0149808D-B2B1-4ABD-B38F-D9D591AC5024</gtr:id><gtr:outcomeId>545d37fb54b7a1.15149797</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>134050</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Dr Hadwen Trust Project Grant</gtr:description><gtr:end>2011-01-02</gtr:end><gtr:fundingOrg>Dr Hadwen Trust (DHT)</gtr:fundingOrg><gtr:id>1D8149C3-1708-4745-B408-250FCC59F162</gtr:id><gtr:outcomeId>3192769A0A10</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>350723</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust PhD Fellowship Scheme (Laura Benjamin)</gtr:description><gtr:end>2013-01-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>858B16FF-26E2-4977-A3E7-E2F81DF216CC</gtr:id><gtr:outcomeId>F05F47DD7AA0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>110000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Meningitis Research Foundation Project Grant</gtr:description><gtr:end>2013-01-02</gtr:end><gtr:fundingOrg>Meningitis Research Foundation</gtr:fundingOrg><gtr:id>95DB482B-6FE2-4080-B62B-8FEF86478FA0</gtr:id><gtr:outcomeId>52AB1C8FB610</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>194860</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>David Sainsbury Fellowship (Dr Adjanie Patabendige)</gtr:description><gtr:end>2015-01-02</gtr:end><gtr:fundingOrg>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs)</gtr:fundingOrg><gtr:id>05FFE605-6076-44E5-B569-BA9217CD9257</gtr:id><gtr:outcomeId>g7EFpxaGm2Z</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>400000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Postdoctoral Training Fellowships for MB/PhD Graduates (Dr Lance Turtle)</gtr:description><gtr:end>2012-01-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>2F91763A-ACE4-4D78-9D44-68FAD10DFC25</gtr:id><gtr:outcomeId>mZ8T8JD6DAQ0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>350000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Fellowship in Clinical Pharmacology and Therpaeutics (Dr Sam Nightingale)</gtr:description><gtr:end>2013-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>4CFE535D-986E-4ABB-BE9D-9CEA7E69EF60</gtr:id><gtr:outcomeId>iTXdddruqAp0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>519000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Zika Rapid Response Initative</gtr:description><gtr:end>2018-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>399C72B2-90D9-477F-A68E-A11C9530D89F</gtr:id><gtr:outcomeId>58be8b56532c17.59507926</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>312810</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Training Fellowship</gtr:description><gtr:end>2008-01-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>E8E931D7-F462-4EF9-9826-5A2269740168</gtr:id><gtr:outcomeId>CE4541D5A100</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>110845</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Training Fellowship</gtr:description><gtr:end>2007-01-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>CF840F5F-10EC-4297-97CB-1101632F5617</gtr:id><gtr:outcomeId>6972DDB1A6C0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1132339</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC/NIHR Efficacy and Mechanism Evaluation (EME) Programme. COHESIVE - COrticosteroids in HErpes SImplex Virus Encephalitis.</gtr:description><gtr:end>2020-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>D243862C-2D93-4E26-81E7-E3B0DC8CF16B</gtr:id><gtr:outcomeId>545d416201ee20.14951132</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-12-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>2016-present Member, WHO Consultation on Considerations for Regulatory Expectations of Zika vaccines for use during an Emergency</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>D3FEAD80-B870-4D43-B5B7-726FBA43648E</gtr:id><gtr:impact>WHO policy on Zika, especially in relation to requirements for vaccine development</gtr:impact><gtr:outcomeId>58c2920245bb41.00403789</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>http://www.who.int/immunization/research/development/WHO_UNICEF_Zikavac_TPP_Feb2017.pdf</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member, National Tuberculosis Meningitis Guidelines Committee</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>767FEC4A-F08E-4D64-A687-042DFD2CD38A</gtr:id><gtr:impact>Improved patient care</gtr:impact><gtr:outcomeId>4356455C3B8</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Adviser: US National Institutes for Health (NIH) Expert Committee on West Nile Virus Treatment</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>9062D595-3E80-44D1-BE0E-D5AA7549D9E4</gtr:id><gtr:impact>Improved outcomes</gtr:impact><gtr:outcomeId>997F90E40C3</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Research through NIHR Health Protection Research Unit on Ebola Virus risk to UK</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>793B1CAF-3C3B-40FC-9015-963AC415993E</gtr:id><gtr:impact>The NIHR HPRU, of which I am the director, is a collaboration between Liverpool and Public Health England (PHE). Our research on risk of Ebola transmission by airline travel and effects of airport screening was fed to DH via PHE to inform policy decisions on protecting the UK from Ebola;</gtr:impact><gtr:outcomeId>54633b862a5933.44985049</gtr:outcomeId><gtr:type>Implementation circular/rapid advice/letter to e.g. Ministry of Health</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member, MRC Training and Careers Group</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>A9DD763B-E994-4930-918E-4A66699346B3</gtr:id><gtr:impact>Hopefully ther group is facilitating training of clinical and non-clinical junior researchers, through a more joined up approahc, and various innovations.</gtr:impact><gtr:outcomeId>ECB40073B88</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member, UK Government's Zika Outbreak Precautionary Scientific Advisory Group for Emergencies (preSAGE)</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>D3EDC9DA-B41D-4A54-8252-FBA8D45A8B57</gtr:id><gtr:impact>Member, UK Government's Zika Outbreak Precautionary Scientific Advisory Group for Emergencies (preSAGE)
Supported policy on travel, risks assessments, developing diagnosis, etc</gtr:impact><gtr:outcomeId>58c2913ceeddb2.56696315</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/584350/160203_PreSAGE_Zika_Minutes_Meeting_1.pdf</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member, Neurology Specialty Group, NIHR Comprehensive Clinical research Network</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>9ACB8980-DB0D-484F-9167-88EDFDD1D36A</gtr:id><gtr:impact>Improved national research portfoilo</gtr:impact><gtr:outcomeId>77D5008BA47</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member, WHO Disease Surveillance Standards, Japanese Encephalitis Case Definitions Committee</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>B021A497-7E77-45F7-8D13-C161A273FF66</gtr:id><gtr:impact>Improved disease surveillance</gtr:impact><gtr:outcomeId>7A8A2B3DB77</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Head of Writing Committee, WHO Consultation on Immunological Endpoints for Evaluation of New Japanese Encephalitis Vaccines</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>1260893A-6329-47CE-AF61-0371600E5D2E</gtr:id><gtr:impact>improved vaccines</gtr:impact><gtr:outcomeId>CA24DEE74F2</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Technical Adviser: WHO Steering Committee Meeting on Japanese encephalitis and Dengue Vaccines</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>C9E1FFEC-2F04-431A-8FD8-0C73BA29060B</gtr:id><gtr:impact>new and imporved vaccines, being implemented more widely; eg 90 million children in India immunized against japanese encephalitis in the last couple of years</gtr:impact><gtr:outcomeId>A4AA977BFC1</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member, Japanese Encephalitis Working Group. World Health Organization</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>48444C81-E4A3-42C2-BA1D-A0A8B64D3BD0</gtr:id><gtr:impact>Improved health care of patients with encephalitis</gtr:impact><gtr:outcomeId>9860270A5A3</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Our reseaerch is cited widely in all the major journals</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>3D070C6F-D40D-41DD-82C9-3A48513E53BA</gtr:id><gtr:impact>No subsequent impact</gtr:impact><gtr:outcomeId>B820C9EBE2B</gtr:outcomeId><gtr:type>Citation in clinical reviews</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>WHO Strategic Advisory Group of Experts on Immunization (SAGE) Working Group on Japanese encephalitis vaccines</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>28F9FD70-AA75-46B7-94CB-8280CC2F7F4C</gtr:id><gtr:outcomeId>HZHJs78NezY</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of SABTO the UK Government's Advisory Committee on the Safety of Blood, Tissues and Organs</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C112CE0A-DA18-4C23-88A3-FD6FAAF7C121</gtr:id><gtr:impact>The Committee advises Ministers of the UK Government and the Devolved Administrations as well as UK Health Departments on the most appropriate ways to ensure the safety of blood, cells, tissues and organs for transfusion / transplantation.

Its remit includes providing independent advice on:
the microbiological safety of gametes and stem cells, in liaison with the relevant regulatory authorities; and risk management options for Ministers and UK Health Departments to consider.</gtr:impact><gtr:outcomeId>pqCLLRvgFRx</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>Intervention
It has been found that many patients with suspected encephalitis are not started on aciclovir treatment within 6 hours, or have an LP performed within the first 12 hours of admission; both of these are key features of the National encephalitis guidelines published in 2012. This study will evaluate both the clinical effectiveness and cost-effectiveness of an intervention to support the implementation of these encephalitis guidelines.
The use of a cluster randomised controlled trial (RCT) in twenty eight hospitals with an evaluation period of 12 months will allow both cost effectiveness and clinical outcomes to be assessed. The intervention will target clinicians responsible for the diagnosis and initial management of suspected encephalitis. Intervention development will be informed by existing evidence on professional behaviour change and sub-studies within the ENCEPH UK programme. This consists of semi structured interviews with health care professionals who have a variety of roles within several hospitals. From this, the major barriers and enablers to using the encephalitis guidelines will be deduced and a novel intervention will be developed and implemented in 14 hospitals over four months, with short training sessions every four months so that staff on new rotations are aware of the intervention over the course of one year.
Primary Outcome
The proportion of patients meeting the definition of suspected encephalitis whose care met all of the following criteria:
Aciclovir given within 6 hours at the appropriate dose unless alternative diagnosis;
A lumbar puncture performed within 12 hours of hospital arrival unless clinically contraindicated; and
If lumbar puncture performed at any time, CSF tested for HSV PCR, and CSF to serum glucose ratio determined.</gtr:description><gtr:id>E1D693BA-2388-4410-ABFB-F3C7BC1D9183</gtr:id><gtr:impact>Cluster RCT</gtr:impact><gtr:outcomeId>545d4c9ec533a5.25948999</gtr:outcomeId><gtr:status>Under active development/distribution</gtr:status><gtr:title>Enceph UK Cluster RCT</gtr:title><gtr:type>Support Tool - For Medical Intervention</gtr:type><gtr:url>http://www.encephuk.org/studies/intervention.aspx</gtr:url><gtr:yearDevCompleted>2014</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>To improve diagnostics of Japanese encephalitis (JE) , the my University of Liverpool (UoL) team worked with colleagues at the University of Malaysia, Sarawak from 1995-8 to develop and field-test simple rapid kits for diagnosing JE in the rural field hospitals where it occurs. Many of these have subsequently been further refined over subsequent years. These diagnostic kits allow JE to be distinguished from the related dengue virus, which can also cause neurological disease, and from other emerging causes of acute central nervous system infection such as enterovirus 71.</gtr:description><gtr:id>BF26132D-D29C-4732-9CB7-E730AF6D157F</gtr:id><gtr:impact>The University of Liverpool (UoL) rapid diagnostic kit for diagnosing Japanese encephalitis (JE) was the prototype for kits developed by the My group at UoL, and others, some of which have gone through to commercialisation , such as that produced by Venture Technologies, Singapore, and since 2008, Pan Bio, Australia, and Excyton Diagnostics, India . Such kits are now widely used across Asia, through the JE laboratory diagnostic network that he UoL helped establish. This is playing an essential role in helping recognition of JE so that the disease burden can be ascertained.</gtr:impact><gtr:outcomeId>sd18XyUCtnM</gtr:outcomeId><gtr:stage>Market authorisation</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Japanes Encephalitis Rapid Diagnostics</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:url>http://www.xcyton.com/</gtr:url><gtr:yearDevCompleted>2010</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>This is a simple clinical outcome score we developed and validated for assessing the outcome of patients that have had encephalitis;</gtr:description><gtr:id>2CDCD581-8136-4790-8E3C-93BA86E5305D</gtr:id><gtr:impact>It is available on the web, and is now being used in India, Nepal, Cambodia, malaysia, Indonesia</gtr:impact><gtr:outcomeId>44D875C7E63</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Liverpool Outcome Score</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>These are simple clinical case defintions that we have now validated and published</gtr:description><gtr:id>8A296389-7F29-4A8E-AA01-D4D940E79D67</gtr:id><gtr:impact>The case definitions have been published and are now widely used across asia</gtr:impact><gtr:outcomeId>FADB416FBD9</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Clinical Cases Definitions for WHO Japanese encephalitis Surveillance Guidelines</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Datbaseprovides infrastructure for the network; allows other research groups to access hospitals and patient cohorts</gtr:description><gtr:id>41431D8E-7494-4C46-BA0F-7E76F5FEBC43</gtr:id><gtr:impact>Supported the establishment of new researches studies, including UK-ChiMES, UK Childhood Meningitis and Encephalitis Study</gtr:impact><gtr:outcomeId>SF3RCiYVUk3</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Brain Infections UK Network of hospitals</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:url>http://www.braininfectionsuk.org/</gtr:url><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>2E8C1507-F1BE-463F-A96E-CB64AFEB2CE7</gtr:id><gtr:title>Polymorphisms of the gene coding for copper/zinc superoxide dismutase (SOD1) in patients with Japanese encephalitis.</gtr:title><gtr:parentPublicationTitle>Annals of tropical medicine and parasitology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6b82001c739ccde119bb9b1fc93d4b9"><gtr:id>c6b82001c739ccde119bb9b1fc93d4b9</gtr:id><gtr:otherNames>Thuong NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0003-4983</gtr:issn><gtr:outcomeId>445E71DE2DA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8CFA183D-15BA-4615-8C66-16335219752D</gtr:id><gtr:title>Human parvovirus 4 as potential cause of encephalitis in children, India.</gtr:title><gtr:parentPublicationTitle>Emerging infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f94303debd4932d3339810b8cfa7df2"><gtr:id>4f94303debd4932d3339810b8cfa7df2</gtr:id><gtr:otherNames>Benjamin LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1080-6040</gtr:issn><gtr:outcomeId>du9vi1qt66y</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF6C2705-291D-4EFF-9A73-9656856673A1</gtr:id><gtr:title>British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children.</gtr:title><gtr:parentPublicationTitle>The Journal of infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40ec8f62afb1d137644703209732a96e"><gtr:id>40ec8f62afb1d137644703209732a96e</gtr:id><gtr:otherNames>Thwaites G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0163-4453</gtr:issn><gtr:outcomeId>08D76CEE7BD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCB14C1B-9913-49C7-AF18-044A97B1F926</gtr:id><gtr:title>Japanese encephalitis: on the One Health agenda.</gtr:title><gtr:parentPublicationTitle>Current topics in microbiology and immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5330e6aa6adf4d804bbb018a7147156a"><gtr:id>5330e6aa6adf4d804bbb018a7147156a</gtr:id><gtr:otherNames>Impoinvil DE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0070-217X</gtr:issn><gtr:outcomeId>pm_17273_23_22886540</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6AD19754-694C-494A-80B3-68229655130E</gtr:id><gtr:title>Structural study of the C-terminal domain of non-structural protein 1 from Japanese encephalitis virus.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4b48981e45fedc2952dbe8e58b648c5"><gtr:id>a4b48981e45fedc2952dbe8e58b648c5</gtr:id><gtr:otherNames>Poonsiri T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>5a9939d0240be6.56107418</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D258A4F1-4FE6-44CE-8113-830C93737798</gtr:id><gtr:title>Breaching the barrier and inflaming epilepsy research.</gtr:title><gtr:parentPublicationTitle>Epilepsy currents</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcc4491c7cede297549b4495861c3a97"><gtr:id>bcc4491c7cede297549b4495861c3a97</gtr:id><gtr:otherNames>Sills GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1535-7511</gtr:issn><gtr:outcomeId>B6E67B8BEC8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>080CBD87-4192-40C6-A0D6-45752795FCBA</gtr:id><gtr:title>Effect of delayed lumbar punctures on the diagnosis of acute bacterial meningitis in adults.</gtr:title><gtr:parentPublicationTitle>Emergency medicine journal : EMJ</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ae11804344cc828efadd010e42b4ff1d"><gtr:id>ae11804344cc828efadd010e42b4ff1d</gtr:id><gtr:otherNames>Michael B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1472-0205</gtr:issn><gtr:outcomeId>Z3hmVU25iW3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F1AD476-D3EF-4ACB-82F2-5DB1C52850DD</gtr:id><gtr:title>Management of suspected herpes simplex virus encephalitis in adults in a U.K. teaching hospital.</gtr:title><gtr:parentPublicationTitle>Clinical medicine (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9753098dee4c865e132b9c314e1db8d4"><gtr:id>9753098dee4c865e132b9c314e1db8d4</gtr:id><gtr:otherNames>Bell DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1470-2118</gtr:issn><gtr:outcomeId>8D3183B8864</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6031E0DB-12AF-439C-85CF-BF9BAB5CCC06</gtr:id><gtr:title>Virology, epidemiology, pathogenesis, and control of enterovirus 71.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d565170e4417b15dd3b581315371bba"><gtr:id>9d565170e4417b15dd3b581315371bba</gtr:id><gtr:otherNames>Solomon T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>P4csunXny85</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05CFCB00-4040-44FB-AA00-3D74AC4ECCD3</gtr:id><gtr:title>Management of suspected viral encephalitis in adults--Association of British Neurologists and British Infection Association National Guidelines.</gtr:title><gtr:parentPublicationTitle>The Journal of infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d565170e4417b15dd3b581315371bba"><gtr:id>9d565170e4417b15dd3b581315371bba</gtr:id><gtr:otherNames>Solomon T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0163-4453</gtr:issn><gtr:outcomeId>pm_17273_23_22120595</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5E1FE7C-DB56-40DB-BA92-85405C568763</gtr:id><gtr:title>Identification and validation of clinical predictors for the risk of neurological involvement in children with hand, foot, and mouth disease in Sarawak.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/814d3a191e6cbf152552e512d43bea0c"><gtr:id>814d3a191e6cbf152552e512d43bea0c</gtr:id><gtr:otherNames>Ooi MH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn><gtr:outcomeId>5E54BEFDC49</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02A665E8-D4B7-40A0-8636-9397EACDF00A</gtr:id><gtr:title>Does antiviral therapy have a role in the control of Japanese encephalitis?</gtr:title><gtr:parentPublicationTitle>Antiviral research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9783e638e2a08e82df63d11ab7d0e169"><gtr:id>9783e638e2a08e82df63d11ab7d0e169</gtr:id><gtr:otherNames>Gould EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0166-3542</gtr:issn><gtr:outcomeId>A969440EF8C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E1F7AA0-B8E5-471E-A840-31D74D33DBE8</gtr:id><gtr:title>Successful treatment of cytomegalovirus polyradiculopathy in a 9-year-old child with congenital human immunodeficiency virus infection.</gtr:title><gtr:parentPublicationTitle>Journal of child neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de9078ee595af0e18ca3e0ff1f4013c2"><gtr:id>de9078ee595af0e18ca3e0ff1f4013c2</gtr:id><gtr:otherNames>Sohal A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0883-0738</gtr:issn><gtr:outcomeId>04BEB6C73FA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2402DC46-229F-45F6-AE06-6E4C6DC46A6B</gtr:id><gtr:title>HIV infection and stroke: current perspectives and future directions.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f94303debd4932d3339810b8cfa7df2"><gtr:id>4f94303debd4932d3339810b8cfa7df2</gtr:id><gtr:otherNames>Benjamin LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>pm_17273_23_22995692</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED53958C-33C1-4191-83F2-DEFEA2F8492E</gtr:id><gtr:title>Acute bacterial meningitis in adults - Authors' reply.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf8effad2a886039558cc0377d3a7ef8"><gtr:id>cf8effad2a886039558cc0377d3a7ef8</gtr:id><gtr:otherNames>McGill F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>5a9939ce1156f1.20925647</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2499D4C0-2B8A-483B-B0F4-1B04E63D794D</gtr:id><gtr:title>Evaluation of two commercially available ELISAs for the diagnosis of Japanese encephalitis applied to field samples.</gtr:title><gtr:parentPublicationTitle>Tropical medicine &amp; international health : TM &amp; IH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3434de58f339c7fb894845a58a22416"><gtr:id>c3434de58f339c7fb894845a58a22416</gtr:id><gtr:otherNames>Lewthwaite P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1360-2276</gtr:issn><gtr:outcomeId>P6JrsPCMfoN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA8DC9A2-ABD6-47B9-9024-D3DDF12A58CE</gtr:id><gtr:title>Suboptimal management of central nervous system infections in children: a multi-centre retrospective study.</gtr:title><gtr:parentPublicationTitle>BMC pediatrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d70dc7bb49a750d51b5f50e44caa910f"><gtr:id>d70dc7bb49a750d51b5f50e44caa910f</gtr:id><gtr:otherNames>Kelly C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-2431</gtr:issn><gtr:outcomeId>pm_17273_23_22958329</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6CA6BFDF-010B-4D8A-9CE8-9005CC30FA0D</gtr:id><gtr:title>What proportion of AQP4-IgG-negative NMO spectrum disorder patients are MOG-IgG positive? A cross sectional study of 132 patients.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b1f1beb264f179102c936f169312006"><gtr:id>5b1f1beb264f179102c936f169312006</gtr:id><gtr:otherNames>Hamid SHM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>5a9939cdc98315.67468520</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8E942FA-CCA4-41A9-9E02-28C024976773</gtr:id><gtr:title>The inter-rater reliability and prognostic value of coma scales in Nepali children with acute encephalitis syndrome.</gtr:title><gtr:parentPublicationTitle>Paediatrics and international child health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fad65768b977156c3a8f8abbb6cc651f"><gtr:id>fad65768b977156c3a8f8abbb6cc651f</gtr:id><gtr:otherNames>Ray S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>2046-9047</gtr:issn><gtr:outcomeId>5a9939cc0fa3f2.54581429</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF90BFAA-C286-4C92-A97A-A75F4D955D71</gtr:id><gtr:title>The Role of Human Immunodeficiency Virus-Associated Vasculopathy in the Etiology of Stroke.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f94303debd4932d3339810b8cfa7df2"><gtr:id>4f94303debd4932d3339810b8cfa7df2</gtr:id><gtr:otherNames>Benjamin LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>5a9939cd886048.26706630</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2168B761-F686-4042-89AD-618D9A441008</gtr:id><gtr:title>Diagnostic accuracy of the Recognition of Stroke in the Emergency Room (ROSIER) score and CT brain in an HIV population.</gtr:title><gtr:parentPublicationTitle>The Journal of infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f94303debd4932d3339810b8cfa7df2"><gtr:id>4f94303debd4932d3339810b8cfa7df2</gtr:id><gtr:otherNames>Benjamin LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0163-4453</gtr:issn><gtr:outcomeId>pm_17273_23_23994064</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27DE92D6-5068-4674-BC84-9B7039D333F1</gtr:id><gtr:title>A cohort study to assess the new WHO Japanese encephalitis surveillance standards.</gtr:title><gtr:parentPublicationTitle>Bulletin of the World Health Organization</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d565170e4417b15dd3b581315371bba"><gtr:id>9d565170e4417b15dd3b581315371bba</gtr:id><gtr:otherNames>Solomon T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0042-9686</gtr:issn><gtr:outcomeId>A9561ADA404</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>005B1C00-0AF7-4FB3-AB0B-3B8C86FD158C</gtr:id><gtr:title>Immunopathogenesis and Virus-Host Interactions of Enterovirus 71 in Patients with Hand, Foot and Mouth Disease.</gtr:title><gtr:parentPublicationTitle>Frontiers in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/358ab537e0144d3dd636ea6d4483d9fe"><gtr:id>358ab537e0144d3dd636ea6d4483d9fe</gtr:id><gtr:otherNames>Cox JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1664-302X</gtr:issn><gtr:outcomeId>5a9939cb6916b8.52404579</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B77E319-0A25-4A73-905E-FB40B5C82080</gtr:id><gtr:title>Post-acute serum eosinophil and neutrophil-associated cytokine/chemokine profile can distinguish between patients with neuromyelitis optica and multiple sclerosis; and identifies potential pathophysiological mechanisms - a pilot study.</gtr:title><gtr:parentPublicationTitle>Cytokine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/facee21ab5659d2ba1eb2649b2422f0f"><gtr:id>facee21ab5659d2ba1eb2649b2422f0f</gtr:id><gtr:otherNames>Michael BD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1043-4666</gtr:issn><gtr:outcomeId>pm_17273_23_23941778</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB6D3B7F-30FB-42E7-8730-D6E55EA32585</gtr:id><gtr:title>Evaluation of different clinical sample types in diagnosis of human enterovirus 71-associated hand-foot-and-mouth disease.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/814d3a191e6cbf152552e512d43bea0c"><gtr:id>814d3a191e6cbf152552e512d43bea0c</gtr:id><gtr:otherNames>Ooi MH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn><gtr:outcomeId>CED2A1080B1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2FB93B6-92E4-4311-A071-76A966E567FC</gtr:id><gtr:title>Acute central nervous system infections in adults--a retrospective cohort study in the NHS North West region.</gtr:title><gtr:parentPublicationTitle>QJM : monthly journal of the Association of Physicians</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/facee21ab5659d2ba1eb2649b2422f0f"><gtr:id>facee21ab5659d2ba1eb2649b2422f0f</gtr:id><gtr:otherNames>Michael BD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1460-2393</gtr:issn><gtr:outcomeId>sumZ2ouVJvT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A833607-93D0-4277-B745-2C22B05512E0</gtr:id><gtr:title>Cellular Immune Responses to Live Attenuated Japanese Encephalitis (JE) Vaccine SA14-14-2 in Adults in a JE/Dengue Co-Endemic Area.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23c0d4ad17a20d254887eaa4c5904fee"><gtr:id>23c0d4ad17a20d254887eaa4c5904fee</gtr:id><gtr:otherNames>Turtle L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>58ba98cf76c714.18793855</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F082B761-86A3-4BDD-B73B-0D803D5B36ED</gtr:id><gtr:title>Clinical features, diagnosis, and management of enterovirus 71.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/814d3a191e6cbf152552e512d43bea0c"><gtr:id>814d3a191e6cbf152552e512d43bea0c</gtr:id><gtr:otherNames>Ooi MH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>TGcnXfZckhv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6ACDF4FE-0C86-41CA-BC5B-7DD4F7B64231</gtr:id><gtr:title>Human enterovirus 71 disease in Sarawak, Malaysia: a prospective clinical, virological, and molecular epidemiological study.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/814d3a191e6cbf152552e512d43bea0c"><gtr:id>814d3a191e6cbf152552e512d43bea0c</gtr:id><gtr:otherNames>Ooi MH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>019F6066B56</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>98648C4F-E2CD-4385-BC60-3457FC6632A9</gtr:id><gtr:title>The epidemiology, clinical features, and long-term prognosis of Japanese encephalitis in central sarawak, malaysia, 1997-2005.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/814d3a191e6cbf152552e512d43bea0c"><gtr:id>814d3a191e6cbf152552e512d43bea0c</gtr:id><gtr:otherNames>Ooi MH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>788C59B1586</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F9C6815-F5C5-46D8-9FED-07AB634C9DA6</gtr:id><gtr:title>The spatial heterogeneity between Japanese encephalitis incidence distribution and environmental variables in Nepal.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5330e6aa6adf4d804bbb018a7147156a"><gtr:id>5330e6aa6adf4d804bbb018a7147156a</gtr:id><gtr:otherNames>Impoinvil DE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>UBvJaEVmquy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CCC92BF0-22E9-48F9-85A4-F03DEE504FD7</gtr:id><gtr:title>Neurological infections: something for everyone.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d565170e4417b15dd3b581315371bba"><gtr:id>9d565170e4417b15dd3b581315371bba</gtr:id><gtr:otherNames>Solomon T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>pm_17273_23_23237897</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D11223A-B4C4-423C-A52F-A74A8D4C581E</gtr:id><gtr:title>Herpes simplex virus encephalitis.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e61d036990408260477fac0fed93aef4"><gtr:id>e61d036990408260477fac0fed93aef4</gtr:id><gtr:otherNames>Egdell R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>56df1c61905840.46107157</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8A9A81CA-E12E-4958-8618-64DC92610161</gtr:id><gtr:title>Estimated global incidence of Japanese encephalitis: a systematic review.</gtr:title><gtr:parentPublicationTitle>Bulletin of the World Health Organization</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0bc216a224f0fc4c8d808671129502b3"><gtr:id>0bc216a224f0fc4c8d808671129502b3</gtr:id><gtr:otherNames>Campbell GL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0042-9686</gtr:issn><gtr:outcomeId>pm_17273_23_22084515</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>995E84B4-5D50-4712-B529-058820D87BEC</gtr:id><gtr:title>Bacterial cell surface display: a method for studying Japanese encephalitis virus pathogenicity.</gtr:title><gtr:parentPublicationTitle>Japanese journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a34d6df7993cfda6b0db83cc6e9611c"><gtr:id>3a34d6df7993cfda6b0db83cc6e9611c</gtr:id><gtr:otherNames>Dou J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1344-6304</gtr:issn><gtr:outcomeId>DCF4DA9A887</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C080210-A340-4BD6-B8DB-83ED1B39468D</gtr:id><gtr:title>Disability after encephalitis: development and validation of a new outcome score.</gtr:title><gtr:parentPublicationTitle>Bulletin of the World Health Organization</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3434de58f339c7fb894845a58a22416"><gtr:id>c3434de58f339c7fb894845a58a22416</gtr:id><gtr:otherNames>Lewthwaite P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0042-9686</gtr:issn><gtr:outcomeId>fXFe3yKugbW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D975AB68-2BB9-40D9-9AA1-5D0749A0CF6E</gtr:id><gtr:title>A Feasibility Study of Quantifying Longitudinal Brain Changes in Herpes Simplex Virus (HSV) Encephalitis Using Magnetic Resonance Imaging (MRI) and Stereology.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16ae741447333f1694fbc08394913726"><gtr:id>16ae741447333f1694fbc08394913726</gtr:id><gtr:otherNames>Defres S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>58ba98cfb1b810.85060601</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31062D9B-ADD8-49BF-84E8-B03198CC12EA</gtr:id><gtr:title>Recombination and positive selection identified in complete genome sequences of Japanese encephalitis virus.</gtr:title><gtr:parentPublicationTitle>Archives of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f5365ad2e3dddc8284e7e77a54175f08"><gtr:id>f5365ad2e3dddc8284e7e77a54175f08</gtr:id><gtr:otherNames>Carney J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0304-8608</gtr:issn><gtr:outcomeId>G2VJm4miMVL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F37DB28E-D9F5-473F-A633-338C48D24228</gtr:id><gtr:title>An evaluation of the usefulness of neuroimaging for the diagnosis of Japanese encephalitis.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b0c67fbde27f721d6a4f8b785b6a3504"><gtr:id>b0c67fbde27f721d6a4f8b785b6a3504</gtr:id><gtr:otherNames>Dung NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>3A50467478E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0AC2DCAF-868E-4918-9372-347EDCD80934</gtr:id><gtr:title>A comparison of HMGB1 concentrations between cerebrospinal fluid and blood in patients with neurological disease.</gtr:title><gtr:parentPublicationTitle>Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2589e0b69b8887580c88c7f00026c23d"><gtr:id>2589e0b69b8887580c88c7f00026c23d</gtr:id><gtr:otherNames>Walker LE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1354-750X</gtr:issn><gtr:outcomeId>5a9939cf9a8131.02502417</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D9CA57D2-2301-4CC2-9F04-28691E2276D7</gtr:id><gtr:title>Enterovirus 75 encephalitis in children, southern India.</gtr:title><gtr:parentPublicationTitle>Emerging infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3434de58f339c7fb894845a58a22416"><gtr:id>c3434de58f339c7fb894845a58a22416</gtr:id><gtr:otherNames>Lewthwaite P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1080-6040</gtr:issn><gtr:outcomeId>ZJFyGKNYNLB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B63A3BD-F1EB-4C8F-8D29-0A7CCEF92F85</gtr:id><gtr:title>Chapter 10 Viral infections of lower motor neurons.</gtr:title><gtr:parentPublicationTitle>Handbook of clinical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d565170e4417b15dd3b581315371bba"><gtr:id>9d565170e4417b15dd3b581315371bba</gtr:id><gtr:otherNames>Solomon T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0072-9752</gtr:issn><gtr:outcomeId>75E82D741A6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D31BA8CC-CD45-4DC6-B1EA-D4F4A1C9F48B</gtr:id><gtr:title>Control of Japanese encephalitis--within our grasp?</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d565170e4417b15dd3b581315371bba"><gtr:id>9d565170e4417b15dd3b581315371bba</gtr:id><gtr:otherNames>Solomon T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>0938622F26A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1063D841-7CF4-4B42-A73D-151771738DE0</gtr:id><gtr:title>Unravelling the neuropathogenesis of Japanese encephalitis.</gtr:title><gtr:parentPublicationTitle>Transactions of the Royal Society of Tropical Medicine and Hygiene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b1c2f430da8671c07b975646f1e556c"><gtr:id>7b1c2f430da8671c07b975646f1e556c</gtr:id><gtr:otherNames>Myint KS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0035-9203</gtr:issn><gtr:outcomeId>AA0038E1D6F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4DE4BF51-4833-42CC-BB95-23FA12CB05A5</gtr:id><gtr:title>Lumbar puncture: diagnosing acute central nervous system infections.</gtr:title><gtr:parentPublicationTitle>Nursing standard (Royal College of Nursing (Great Britain) : 1987)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ef95d7693c769dd4cae27c0185e8e339"><gtr:id>ef95d7693c769dd4cae27c0185e8e339</gtr:id><gtr:otherNames>Matata C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0029-6570</gtr:issn><gtr:outcomeId>pm_17273_23_23189602</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>73DE98CD-3BD3-45CB-9B54-A0BF75BE2DFC</gtr:id><gtr:title>Development and characterization of non-glycosylated E and NS1 mutant viruses as a potential candidate vaccine for West Nile virus.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/305a83abbc0caa2e63c465021254e37e"><gtr:id>305a83abbc0caa2e63c465021254e37e</gtr:id><gtr:otherNames>Whiteman MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>1BC638836F6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D4BCF02-C5BD-445D-BC97-49FF8847BDD1</gtr:id><gtr:title>The incidence of acute encephalitis syndrome in Western industrialised and tropical countries.</gtr:title><gtr:parentPublicationTitle>Virology journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d18437f6b12d9e3d55ef120db45ed9ab"><gtr:id>d18437f6b12d9e3d55ef120db45ed9ab</gtr:id><gtr:otherNames>Jmor F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1743-422X</gtr:issn><gtr:outcomeId>F23A3ADC950</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD3A7537-EA98-4F18-81CF-30D0D932A851</gtr:id><gtr:title>In enterovirus 71 encephalitis with cardio-respiratory compromise, elevated interleukin 1?, interleukin 1 receptor antagonist, and granulocyte colony-stimulating factor levels are markers of poor prognosis.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cb3ca4abdb659bf813e0fd60eeac62db"><gtr:id>cb3ca4abdb659bf813e0fd60eeac62db</gtr:id><gtr:otherNames>Griffiths MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>pm_17273_23_22829643</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F3A0AFA-5A9A-4DD3-955E-77911D31AEED</gtr:id><gtr:title>Improving the diagnosis of central nervous system infections in adults through introduction of a simple lumbar puncture pack.</gtr:title><gtr:parentPublicationTitle>Emergency medicine journal : EMJ</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/facee21ab5659d2ba1eb2649b2422f0f"><gtr:id>facee21ab5659d2ba1eb2649b2422f0f</gtr:id><gtr:otherNames>Michael BD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1472-0205</gtr:issn><gtr:outcomeId>pm_17273_23_22707473</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>64A519B0-D16F-4CC2-8A87-6DA091F012DB</gtr:id><gtr:title>The trials and tribulations of implementing a multi-centre study of encephalitis in England.</gtr:title><gtr:parentPublicationTitle>Clinical medicine (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b83296a77828a8a9eccfecba1c922a58"><gtr:id>b83296a77828a8a9eccfecba1c922a58</gtr:id><gtr:otherNames>Granerod J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1470-2118</gtr:issn><gtr:outcomeId>BC506698854</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BDC71D5-FAA3-4D76-9B37-4C6DB77E87E1</gtr:id><gtr:title>The functional, social and economic impact of acute encephalitis syndrome in Nepal--a longitudinal follow-up study.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cb3ca4abdb659bf813e0fd60eeac62db"><gtr:id>cb3ca4abdb659bf813e0fd60eeac62db</gtr:id><gtr:otherNames>Griffiths MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>pm_17273_23_24069467</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5135FBA9-C98B-47AE-82ED-0853515880C2</gtr:id><gtr:title>Encephalitis caused by flaviviruses.</gtr:title><gtr:parentPublicationTitle>QJM : monthly journal of the Association of Physicians</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23c0d4ad17a20d254887eaa4c5904fee"><gtr:id>23c0d4ad17a20d254887eaa4c5904fee</gtr:id><gtr:otherNames>Turtle L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1460-2393</gtr:issn><gtr:outcomeId>pm_17273_23_22367423</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E7F48F6-7679-439F-87DC-F569C734F507</gtr:id><gtr:title>Molecular phylogenetic and evolutionary analyses of Muar strain of Japanese encephalitis virus reveal it is the missing fifth genotype.</gtr:title><gtr:parentPublicationTitle>Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/534da179ef66360293d1ea32201fc21f"><gtr:id>534da179ef66360293d1ea32201fc21f</gtr:id><gtr:otherNames>Mohammed MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1567-1348</gtr:issn><gtr:outcomeId>g6ZwK6msNtk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23A8B812-E561-48F8-9594-0A69B8F9E256</gtr:id><gtr:title>The management of infants and children treated with aciclovir for suspected viral encephalitis.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c5a2cf6ed35d56cc76435159b318f64"><gtr:id>4c5a2cf6ed35d56cc76435159b318f64</gtr:id><gtr:otherNames>Kneen R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0003-9888</gtr:issn><gtr:outcomeId>62F1EBAD6EC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91842891-AFDE-4895-949F-197BDD505224</gtr:id><gtr:title>Current use and development of vaccines for Japanese encephalitis.</gtr:title><gtr:parentPublicationTitle>Expert opinion on biological therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7855a602793edb54e41a189351fdae9b"><gtr:id>7855a602793edb54e41a189351fdae9b</gtr:id><gtr:otherNames>Beasley DW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1471-2598</gtr:issn><gtr:outcomeId>7A15D9C84C7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02E0E52D-8BC2-4F6B-B841-BC5167123C90</gtr:id><gtr:title>Seizures and Encephalitis in Myelin Oligodendrocyte Glycoprotein IgG Disease vs Aquaporin 4 IgG Disease.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b1f1beb264f179102c936f169312006"><gtr:id>5b1f1beb264f179102c936f169312006</gtr:id><gtr:otherNames>Hamid SHM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>5a9939cc4f4e97.99685426</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4773FC62-11BC-4EA7-B8EF-DE2E67B9F891</gtr:id><gtr:title>Clinical and prognostic features among children with acute encephalitis syndrome in Nepal; a retrospective study.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be77e2539cd28d2d15c600f7c64e4379"><gtr:id>be77e2539cd28d2d15c600f7c64e4379</gtr:id><gtr:otherNames>Rayamajhi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn><gtr:outcomeId>pm_17273_23_22035278</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B88E0DE3-C6B8-4C46-9DA4-20CEBC2EA1E5</gtr:id><gtr:title>Chikungunya virus and central nervous system infections in children, India.</gtr:title><gtr:parentPublicationTitle>Emerging infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3434de58f339c7fb894845a58a22416"><gtr:id>c3434de58f339c7fb894845a58a22416</gtr:id><gtr:otherNames>Lewthwaite P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1080-6040</gtr:issn><gtr:outcomeId>0FDD13B878E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36B0B18F-42CC-446C-A86F-DCE1F5630AB2</gtr:id><gtr:title>Pathogenic flaviviruses.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9783e638e2a08e82df63d11ab7d0e169"><gtr:id>9783e638e2a08e82df63d11ab7d0e169</gtr:id><gtr:otherNames>Gould EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>F5B489B0162</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0AF4ADAA-B404-4F41-95C9-4333A85E2F84</gtr:id><gtr:title>Viral encephalitis: a clinician's guide.</gtr:title><gtr:parentPublicationTitle>Practical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d565170e4417b15dd3b581315371bba"><gtr:id>9d565170e4417b15dd3b581315371bba</gtr:id><gtr:otherNames>Solomon T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1474-7758</gtr:issn><gtr:outcomeId>393EDD1D5C1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4140AF2-5982-4B7A-ADBA-0122B086C524</gtr:id><gtr:title>ZikaPLAN: Zika Preparedness Latin American Network.</gtr:title><gtr:parentPublicationTitle>Global health action</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f1768d63db46fe1232e38d9e98fed07c"><gtr:id>f1768d63db46fe1232e38d9e98fed07c</gtr:id><gtr:otherNames>Wilder-Smith A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1654-9880</gtr:issn><gtr:outcomeId>5a9939cbc49975.32149786</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B6FB6BB-23ED-4CD4-BAEE-9BB616BF5DE2</gtr:id><gtr:title>The effect of vaccination coverage and climate on Japanese encephalitis in Sarawak, Malaysia.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5330e6aa6adf4d804bbb018a7147156a"><gtr:id>5330e6aa6adf4d804bbb018a7147156a</gtr:id><gtr:otherNames>Impoinvil DE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>pm_17273_23_23951373</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DCA977C5-B130-4D04-9769-53A8CADBC29D</gtr:id><gtr:title>Case report: Eastern equine encephalitis virus imported to the UK.</gtr:title><gtr:parentPublicationTitle>Journal of medical virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ccb6b661290ee4579560828ec2640702"><gtr:id>ccb6b661290ee4579560828ec2640702</gtr:id><gtr:otherNames>Harvala H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0146-6615</gtr:issn><gtr:outcomeId>CF97CACC86F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>913CEC64-C3EA-4D9F-8E08-E59E412EA076</gtr:id><gtr:title>The spectrum of neurological disease associated with Zika and chikungunya viruses in adults in Rio de Janeiro, Brazil: A case series.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3090473dddbf702dd6b298ee25cdf4e7"><gtr:id>3090473dddbf702dd6b298ee25cdf4e7</gtr:id><gtr:otherNames>Mehta R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>5a9939cfd53c08.91139967</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D71F79D-9C53-43EF-8DAB-1BDBFC9EBC16</gtr:id><gtr:title>HIV dementia: a diagnosis to keep in mind.</gtr:title><gtr:parentPublicationTitle>British journal of hospital medicine (London, England : 2005)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9dd96bb733c0726221ef84de4144119"><gtr:id>f9dd96bb733c0726221ef84de4144119</gtr:id><gtr:otherNames>Kelly CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1750-8460</gtr:issn><gtr:outcomeId>pm_17273_23_22875438</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77116F2F-25C1-4467-9808-0D255B7780C6</gtr:id><gtr:title>Viral CNS infections in children from a malaria-endemic area of Malawi: a prospective cohort study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Global health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0f67f80f52de0336a2c9509411945c2"><gtr:id>f0f67f80f52de0336a2c9509411945c2</gtr:id><gtr:otherNames>Mallewa M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2214-109X</gtr:issn><gtr:outcomeId>585d5a345ea4f2.68544295</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF747BBB-06C1-4DC8-BF5B-9F861CB2467C</gtr:id><gtr:title>Rabies encephalitis in malaria-endemic area, Malawi, Africa.</gtr:title><gtr:parentPublicationTitle>Emerging infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0f67f80f52de0336a2c9509411945c2"><gtr:id>f0f67f80f52de0336a2c9509411945c2</gtr:id><gtr:otherNames>Mallewa M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1080-6040</gtr:issn><gtr:outcomeId>4B5B182F84F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5CAAAE13-10B0-4D3D-969D-9A3BC1B5FFCA</gtr:id><gtr:title>Management of suspected viral encephalitis in children - Association of British Neurologists and British Paediatric Allergy, Immunology and Infection Group national guidelines.</gtr:title><gtr:parentPublicationTitle>The Journal of infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c5a2cf6ed35d56cc76435159b318f64"><gtr:id>4c5a2cf6ed35d56cc76435159b318f64</gtr:id><gtr:otherNames>Kneen R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0163-4453</gtr:issn><gtr:outcomeId>pm_17273_23_22120594</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF25008D-D761-4756-AF26-61C428FC250C</gtr:id><gtr:title>Detection of herpes viruses in the cerebrospinal fluid of adults with suspected viral meningitis in Malawi.</gtr:title><gtr:parentPublicationTitle>Infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f94303debd4932d3339810b8cfa7df2"><gtr:id>4f94303debd4932d3339810b8cfa7df2</gtr:id><gtr:otherNames>Benjamin LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0300-8126</gtr:issn><gtr:outcomeId>pm_17273_23_22798048</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5C2C670-870D-4E9F-8BA9-26768E382E7D</gtr:id><gtr:title>Prior Dengue virus exposure shapes T cell immunity to Zika virus in humans.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34e2a1cee9930c527a685788cf1b8930"><gtr:id>34e2a1cee9930c527a685788cf1b8930</gtr:id><gtr:otherNames>Grifoni A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>5a9939cd0ee6d4.99311906</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5187EB16-9EAB-46BF-A2F5-98EDC4FDF81B</gtr:id><gtr:title>Tick-borne encephalitis virus - a review of an emerging zoonosis.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/09f1a165c10a6aa9aff46fdbec5f3e42"><gtr:id>09f1a165c10a6aa9aff46fdbec5f3e42</gtr:id><gtr:otherNames>Mansfield KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>EE5F2CB6C95</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E93BD517-CE7C-4C92-A233-992D2A949065</gtr:id><gtr:title>Seizures and encephalitis: clinical features, management, and potential pathophysiologic mechanisms.</gtr:title><gtr:parentPublicationTitle>Epilepsia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/facee21ab5659d2ba1eb2649b2422f0f"><gtr:id>facee21ab5659d2ba1eb2649b2422f0f</gtr:id><gtr:otherNames>Michael BD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0013-9580</gtr:issn><gtr:outcomeId>pm_17273_23_22946723</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8531F615-95FB-45B4-9885-7B96D5D60E28</gtr:id><gtr:title>Recurrent myositis triggered by infections: a case report.</gtr:title><gtr:parentPublicationTitle>Journal of medical case reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3af41585d570dd3045c7661eaf6dae62"><gtr:id>3af41585d570dd3045c7661eaf6dae62</gtr:id><gtr:otherNames>Wong SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1752-1947</gtr:issn><gtr:outcomeId>4F75112A32B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C592A94-BD1D-4DAE-8A15-9F12B2520E4F</gtr:id><gtr:title>Brain biopsy in the management of neurology patients.</gtr:title><gtr:parentPublicationTitle>European neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3af41585d570dd3045c7661eaf6dae62"><gtr:id>3af41585d570dd3045c7661eaf6dae62</gtr:id><gtr:otherNames>Wong SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0014-3022</gtr:issn><gtr:outcomeId>BDuegPungkz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>538D0406-06B2-43BC-B249-0C13A3FFF1CD</gtr:id><gtr:title>Epstein-barr virus coinfection in cerebrospinal fluid is associated with increased mortality in Malawian adults with bacterial meningitis.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e2d33a02847fc49796604f354000542"><gtr:id>2e2d33a02847fc49796604f354000542</gtr:id><gtr:otherNames>Kelly MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>Q4V4YfLrw3f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>135C9734-4148-4BD4-AFB7-B91EB1A72077</gtr:id><gtr:title>New vaccines for Japanese encephalitis.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d565170e4417b15dd3b581315371bba"><gtr:id>9d565170e4417b15dd3b581315371bba</gtr:id><gtr:otherNames>Solomon T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>ED8E87EE9E7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E7CB7B5-2176-4467-AB46-66971A39ECEE</gtr:id><gtr:title>A preliminary neuropathological study of Japanese encephalitis in humans and a mouse model.</gtr:title><gtr:parentPublicationTitle>Transactions of the Royal Society of Tropical Medicine and Hygiene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a65f70c3eabe63fe37981dca88bd7cf1"><gtr:id>a65f70c3eabe63fe37981dca88bd7cf1</gtr:id><gtr:otherNames>German AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0035-9203</gtr:issn><gtr:outcomeId>5F35F4CEF4A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>931409D2-ABFB-47AE-AF8A-5284B8A1304B</gtr:id><gtr:title>Challenges of stroke management in resource-limited settings: A case-based reflection.</gtr:title><gtr:parentPublicationTitle>Malawi medical journal : the journal of Medical Association of Malawi</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a8485ebfa54e3677fd2fde6109ddf13"><gtr:id>7a8485ebfa54e3677fd2fde6109ddf13</gtr:id><gtr:otherNames>Gadama YG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1995-7262</gtr:issn><gtr:outcomeId>5a9939cd522a24.34347112</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20A318C4-F9D7-4897-96D5-F804CFC7B4BD</gtr:id><gtr:title>Management of acute confusion in patients with CNS infections.</gtr:title><gtr:parentPublicationTitle>Nursing standard (Royal College of Nursing (Great Britain) : 1987)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ef95d7693c769dd4cae27c0185e8e339"><gtr:id>ef95d7693c769dd4cae27c0185e8e339</gtr:id><gtr:otherNames>Matata C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0029-6570</gtr:issn><gtr:outcomeId>545d330d2b4c54.14053102</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F3A664B1-7EB3-4568-AFF3-8C62F0636DAB</gtr:id><gtr:title>Global Assessment of Dengue Virus-Specific CD4T Cell Responses in Dengue-Endemic Areas.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34e2a1cee9930c527a685788cf1b8930"><gtr:id>34e2a1cee9930c527a685788cf1b8930</gtr:id><gtr:otherNames>Grifoni A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>5a9939cc940a53.54724693</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G116/194</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>